StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com

Lunai Bioworks Files Form 15-12G to Deregister Common Stock

Lunai Bioworks filed a Form 15-12G with the SEC on Nov. 12, 2026, to terminate registration of its common stock and suspend its reporting obligations.

What happened

Lunai Bioworks, Inc., a pharmaceutical preparations company based in Sacramento, California, filed a Form 15-12G with the U.S. Securities and Exchange Commission on Nov. 12, 2026.

The filing covers the company's common stock, par value $0.0001 per share, and states there are no other classes of securities for which a reporting duty under Section 13(a) or 15(d) of the Securities Exchange Act of 1934 remains.

The filing lists approximately 231 holders of record as of the certification date. It was signed by Chief Executive Officer David Weinstein.

The filing does not state why the company is deregistering. The source document contains no explanation of the decision beyond the certification itself.

What this means

A Form 15 is the document a company files with the SEC to end its status as a reporting issuer. Once it takes effect, the company no longer has to file annual reports (Form 10-K), quarterly reports (Form 10-Q) or current reports (Form 8-K) with the regulator.

The form offers several rule provisions as checkboxes, each covering a different legal route to deregistration. In this filing, the boxes for Rule 12g-4(a)(1), 12g-4(a)(2), 12h-3(b)(1)(i), 12h-3(b)(1)(ii), 15d-6 and 15d-22(b) are all shown without a visible mark in the text provided, so the source does not make clear which provision the company is relying on.

The 'holders of record' figure of 231 is not the same as the number of investors who own the stock. It counts the accounts listed on the company's register, which are often brokers holding shares on behalf of many clients. Deregistration thresholds under the Exchange Act are generally tested against holders of record, and a small count is one common basis for eligibility.

Deregistration is distinct from delisting. A delisting removes a stock from an exchange such as Nasdaq or NYSE; this filing terminates SEC registration and the duty to file periodic reports. The filing does not say whether the stock has been or will be delisted, and it does not name an exchange.

What happens next is governed by SEC rules: the termination typically becomes effective 90 days after the filing, or sooner in some circumstances. The filing itself contains no statement about the company's plans, its financial condition, or where its shares will trade afterward.

Sources

Information summarized by AI from the sources listed above. May contain errors — informational only, not investment advice.